Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 695-702

  Sarich, Troy C ^a,b   Adams, Stephen P ^a   Petricca, Giorgio ^a   Wright, James M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOHYDRAZIDE; AMIDASE INHIBITOR; BIS(4 NITROPHENYL) PHOSPHATE; CYTOCHROME P450; ENZYME INHIBITOR; GLUTATHIONE; HYDRALAZINE; ISONIAZID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INHIBITION; DRUG METABOLISM; LIVER CELL DAMAGE; LIVER MICROSOME; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

AMIDOHYDROLASES; ANIMALS; ANTITUBERCULAR AGENTS; CYTOCHROME P-450 CYP2E1; ENZYME INHIBITORS; GLUTATHIONE; HEPATITIS, TOXIC; HYDRAZINES; ISONIAZID; MALE; MICROSOMES, LIVER; NITROPHENOLS; RABBITS; TRIGLYCERIDES;

EID: 0032927195     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Aix L, Rey-Grobellet X, Larrieu G, Lesca P and Galtier P (1994) Thiabendazole is an inducer of cytochrome P4501A1 in cultured rabbit hepatocytes. Biochem Biophys Res Commun 202:1483-1489.
2. Albano E, Comoglio A, Clot P, Iannone A, Tomasi A and Ingelman-Sundberg M (1995) Activation of alkylhydrazines to free radical intermediates by ethanol-inducible cytochrome P-4502E1 (CYP2E1). Biochim Biophys Acta 1243:414-420.
3. Barlow PB, Black M, Brummer DL, Comstock GW, Dubin IN, Enterline P, Gibson ML, Hardy GE Jr, Harrel JA, Johnston RF, Kent DC, Marvin BA, McCaig NC, Mitchell JR, Mosley JW, Ogasawara FR, Popper H, Reichman LB and Zimmerman HJ (1974) Preventive therapy of tuberculous infection. Am Rev Respir Dis 110: 371-374.
4. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Ann Biochem 72:248-254.
5. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T and Mayer RT (1985) Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34:3337-3345.
6. Campanini RZ, Tapia RA, Sarnat W and Natelson S (1970) Evaluation of serum argininosuccinate lyase (ASAL) concentrations as an index to parenchymal liver disease. Clin Chem 16:44-53.
7. Gent WL, Seifart HI, Parkin DP, Donald PR and Lamprecht JH (1992) Factors in hydrazine formation from isoniazid by paediatric and adult tuberculous patients. Eur J Clin Pharmacol 43:131-136.
8. Grimm SW, Dyroff MC, Philpot RM and Halpert JR (1994) Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: Implications of the cytochrome P450 2B5 polymorphism. Mol Pharmacol 46:1090-1099.
9. 1 on liver drug metabolizing enzymes in rabbit. Toxicology 108:39-48.
10. Heymann E and Krisch K (1967) Phosphorsäure-bis-(p-nitrophenylester), ein neuer hemmstoff mikrosomaler carboxylesterasen. Z Physiol Chem 348:609-619.
11. Heymann E and Krisch K (1969) Inhibition of phenacetin- and acetanilide-induced methemoglobinemia in the rat by the carboxylesterase inhibitor bis-(p-nitrophenyl) phosphate. Biochem Pharmacol 18:801-811.
12. Jenner AM and Timbrell JA (1994) Effect of acute and repeated exposure to low-doses of hydrazine on hepatic microsomal enzymes and biochemical parameters in vivo. Arch Toxicol 68:240-245.
13. Koop DR (1986) Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cyp P-450 isozyme 3a. Mol Pharmacol 28:399-404.
14. Maddrey WC and Boitnott JK (1973) Isoniazid hepatitis. Ann Intern Med 79:1-12.
15. Mandl J, Bánhegyi G, Kalapos MP and Garzó T (1995) Increased oxidation and decreased conjugation of drugs in the liver caused by starvation. Altered metabolism of certain aromatic compounds and acetone. Chem-Biol Interact 96:87-101.
16. Mitchell JR, Long MW, Thorgeirsson UP and Jollow DJ (1975) Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy. Chest 68:181-190.
17. Mitchell JR, Zimmerman HJ, Ishak KG, Thorgeirsson UP, Timbrell JA, Snodgrass WR and Nelson SD (1976) Isoniazid liver injury: Clinical spectrum, pathology and probable pathogenesis. Ann Intern Med 84:181-192.
18. Moron MS, DePierre JW and Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67-78.
19. Noda A, Hsu K-Y, Noda H, Yamamoto Y and Kurozumi T (1983) Is isoniazid-hepatotoxicity induced by the metabolite hydrazine? J UOEH 5:183-190.
20. Patrick RL and Back KC (1965) Pathology and toxicology of repeated doses of hydrazine and 1,1-dimethylhydrazine in monkeys and rats. Ind Med Surg 34:430-435.
21. Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP and Yang CS (1993) Cytochrome P-450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 6:511-518.
22. Peretti E, Karlaganis G and Lauterburg BH (1987) Increased urinary excretion of toxic hydrazino metabolites of isoniazid by slow acetylators. Effect of a slow-release preparation of isoniazid. Eur J Clin Pharmacol 33:283-286.
23. Pessayre D, Dolder A, Artigou J-Y, Wandscheer J-C, Descatoire V, Degott C and Benhamou J-P (1979) Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology 77:264-271.
24. Phillips AH and Langdon RG (1962) Hepatic triphosphopyridine nucleotide-cytochrome c reductase: Isolation, characterization, and kinetic studies. J Biol Chem 287:2652-2660.
25. Pumford NR and Halmes NC (1997) Protein targets of xenobiotic reactive intermediates. Annu Rev Pharmacol Toxicol 37:91-117.
26. Raucy JL, Lasker JM, Lieber CS and Black M (1989) Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys 271:270-283.
27. Reinke LA and Moyer MJ (1985) p-Nitrophenyl hydroxylation: A microsomal oxidation which is highly inducible by ethanol. Drug Metab Dispos 13:548-552.
28. Rey-Grobellet X, Ferre N, Eeckhoutte C, Larrieu G, Pineau T and Galtier P (1996) Structural requirements for the induction of cytochromes P450 by benzimidazole anthelmintic derivatives in cultured rabbit hepatocytes. Biochem Biophys Res Commun 220:789-794.
29. Sarich TC, Adams SP and Wright JM (1998) The role of L-thyroxine and hepatic reductase activity in isoniazid-induced hepatotoxicity in rabbits. Pharmacol Res 38(Suppl 3):199-207.
30. Sarich TC, Youssefi M, Zhou T, Adams SP, Wall RA and Wright JM (1996) The role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits. Arch Toxicol 70:835-840.
31. Sarich TC, Zhou T, Adams SP, Bain AI, Wall RA and Wright JM (1995) A model of isoniazid-induced hepatotoxicity in rabbits. J Pharmacol Toxicol Methods 34:109-116.
32. Sendo T, Noda A, Noda H, Hsu K-Y and Yamamoto Y (1984) Metabolic hydrolysis of isoniazid by subcellular fractions of rat liver. J UOEH 6:249-255.
33. Sims FH and Rautanen P (1975) Serum arginino-succinate lyase: Observations on the sensitivity and specificity of this test in the detection of minimal hepatocellular damage. Clin Biochem 8:213-221.
34. Snawder JE, Roe AL, Benson RW and Roberts DW (1994) Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: Relation to toxicity, Biochem Biophys Res Commun 203:532-539.
35. Thummel KE, Lee CA, Kunze KL, Nelson SD and Slattery JT (1993) Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol 45:1563-1569.
36. Whitehouse LW, Tryphonas L, Paul CJ, Solomonraj G, Thomas BH and Wong LT (1983) Isoniazid-induced hepatic steatosis in rabbits: An explanation for susceptibility and its antagonism by pyridoxine hydrochloride. Can J Physiol Pharmacol 61:478-487.
37. Woo J, Chan CHS, Walubo A and Chan KKC (1992) Hydrazine: A possible cause of isoniazid-induced hepatic necrosis. J Med 23:51-59.
38. Yard AS and McKennis H Jr (1955) Effect of structure on the ability of hydrazino compounds to produce fatty livers. J Pharmacol Exp Ther 114:391-397.
39. Zand R, Nelson SD, Slattery JT, Thummel KE, Kalhorn TF, Adams SP and Wright JM (1993) Inhibition and induction of cytochrome P-4502El-catalyzed oxidation by isoniazid in humans. Clin Pharmacol Ther 54:142-149.
40. Zar JH (1984) Biostatistical Analysis Prentice-Hall Canada, Inc., Toronto.